26.59
+2.15%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Tactile Systems Technology
From its filings with the US Securities and Exchange Commission
Tactile Systems Technology is based in Minneapolis, Minnesota and is incorporated in Minnesota. Its shares trade on Nasdaq under the ticker TCMD. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported revenue of $329.5m and net income of $19.1m. At that date it held total assets of $273.9m and shareholders' equity of $218.9m.
Tactile Systems Technology, Inc. (“we,” “us,” and “our”) is a medical technology company that develops and provides innovative medical devices for the treatment of underserved chronic diseases. We were originally incorporated in Minnesota under the name Tactile Systems Technology, Inc. on January 30, 1995. During 2006, we established a merger corporation and subsequently, on July 21, 2006, merged with and into this merger corporation resulting in us being reincorporated as a Delaware corporation. The resulting corporation assumed the name Tactile Systems Technology, Inc. and in September 2013, we began doing business as “Tactile Medical”.
Our mission is to help people suffering from chronic diseases live better and care for themselves at home. We focus our efforts on advancing the standard of care in treating underserved chronic diseases in the home to improve patient outcomes and quality of life and help control rising healthcare expenditures. Our areas of therapeutic focus are (1) vascular disease, with a goal of advancing the standard of care in treating lymphedema and chronic venous insufficiency, (2) oncology, where lymphedema is a common consequence among cancer survivors and (3) providing airway clearance therapy for those suffering from chronic respiratory conditions. We possess a unique, scalable platform to deliver at-home healthcare solutions throughout the United States. This evolving home care delivery model is recognized by policymakers and insurance payers as a key for controlling rising healthcare costs.
Quoted from its 10-K, filed 17 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 28 Jul 2016
- Employees
- 1,086
- Website
- tactilemedical.com ↗
- Head office
- 1331 TYLER STREET NE STE 200, MINNEAPOLIS, MN, 55413
- Incorporated in
- MN
- Classification
- Surgical & Medical Instruments & Apparatus
- Filer status
- Accelerated filer
Leadership
Pay as last reported
- Mr. William BurkeIndependent Chairman of the Board$252,496
- Ms. Sheri DoddChief Executive Officer, Director, since 2021$2.5m
- Ms. Elaine BirkemeyerChief Financial Officer$1.4m
- Ms. Kristie BurnsSenior Vice President - Marketing and Clinical Affairs$1.0m
- Ms. Laura KingDirector
- Ms. Valerie AsburyIndependent Director$214,996
- Mr. Raymond HuggenbergerIndependent Director$214,996
- Mr. D. Brent ShaferIndependent Director$212,496
- Ms. Carmen VolkartIndependent Director$222,496
- Dr. B. Vindell WashingtonIndependent Director$209,996
- Mr. Sam BentzingerInvestor Relations Contact Officer, since 2023
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 54
- Environment
- 10
- Social
- 86
- Governance
- 66
- Women in the workforce
- 64%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Tactile Systems Technology Inc has several strengths that contribute to its success in the market. Firstly, the company has developed innovative medical devices that provide effective treatment for lymphedema and other chronic swelling disorders. These devices are widely recognized for their quality and efficacy.
- The company also benefits from a strong market position and reputation. It has established strong relationships with key healthcare professionals and institutions, enabling it to gain significant market share. This has further led to a growing customer base and increased revenue for the company.
- Additionally, Tactile Systems Technology Inc invests heavily in research and development, allowing it to continuously improve and expand its product offerings. This commitment to innovation ensures that the company stays at the forefront of technological advancements in the medical device industry.
Weaknesses
- Despite its strengths, Tactile Systems Technology Inc does face certain weaknesses that could potentially hinder its growth. One of the main weaknesses is the high cost of its medical devices. This can limit the company's reach, as affordability remains a concern for some potential customers and healthcare providers.
- Another weakness is the company's dependence on a limited number of key suppliers. Any disruptions in the supply chain could negatively impact production and lead to potential delays in fulfilling orders. It is crucial for the company to diversify its supplier base to mitigate this risk.
Opportunities
- Tactile Systems Technology Inc operates in a growing market with increasing awareness about lymphedema and its treatment. This presents significant opportunities for the company to expand its customer base and market presence. The rising aging population and prevalence of chronic diseases further contribute to the potential for increased demand for its products.
- Furthermore, the company can explore international markets to further drive its growth. Expansion into untapped regions and collaborations with global distributors can help Tactile Systems Technology Inc establish a strong foothold in new markets.
Threats
- Tactile Systems Technology Inc faces various threats that could impact its operations and market position. One of the primary threats is intense competition from existing and emerging medical device manufacturers. Competitors with similar or potentially superior products can pose a challenge, forcing the company to continuously innovate and differentiate itself.
- Another threat is the evolving regulatory environment. Compliance with changing regulations and obtaining necessary approvals for new products can be time-consuming and costly, potentially affecting the company's ability to introduce and market its innovations in a timely manner.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.